KLRK1 and neoplasm: Tumor-associated T-reg cells were found to be positive for the expression of NKG2D ligand surface expression and were found to be killed by T cells expressing chimeric NKG2D (chNKG2D) receptors due to receptor–ligand interaction in a perforin-dependent manner [60].